Cdld-structure-carbidopa (Cdld Structure Carbidopa)
Carbidopa And Levodopa Tablet
Product Images NDC 63629-9154
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 63629-9154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cdld-structure-levodopa (Cdld Structure Levodopa)
Label (Lbl636299154)
Carbidopa and Levodopa Tablets are used to treat symptoms of Parkinson's disease including tremors, stiffness, and difficulty in movement. Each tablet contains 25mg Carbidopa USP and 250mg Levodopa USP. It is recommended to store the medication in a tightly closed container, protected from light and moisture, and at controlled room temperature. This medication should be dispensed in a tight, light-resistant container and kept out of reach of children. This product is available in tablet form and supplied in a package containing 100 tablets.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
